These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25735870)

  • 1. Simultaneous quantification of digoxin, digitoxin, and their metabolites in serum using high performance liquid chromatography-tandem mass spectrometry.
    Bylda C; Thiele R; Kobold U; Volmer DA
    Drug Test Anal; 2015 Oct; 7(10):937-46. PubMed ID: 25735870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the cardiac glycosides digoxin and digitoxin by liquid chromatography combined with isotope-dilution mass spectrometry (LC-IDMS)--a candidate reference measurement procedure.
    Kaiser P; Kramer U; Meissner D; Kress M; Wood WG; Reinauer H
    Clin Lab; 2003; 49(7-8):329-43. PubMed ID: 12908733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of digoxin and digitoxin in whole blood.
    Oiestad EL; Johansen U; Stokke Opdal M; Bergan S; Christophersen AS
    J Anal Toxicol; 2009 Sep; 33(7):372-8. PubMed ID: 19796507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and application of a 96-well format solid-phase extraction and liquid chromatography-tandem mass spectrometry method for the quantitation of digoxin in human plasma.
    Hashimoto Y; Shibakawa K; Nakade S; Miyata Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):126-32. PubMed ID: 18515196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid quantification of digitoxin and its metabolites using differential ion mobility spectrometry-tandem mass spectrometry.
    Bylda C; Thiele R; Kobold U; Bujotzek A; Volmer DA
    Anal Chem; 2015 Feb; 87(4):2121-8. PubMed ID: 25588102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and simultaneous measurement of midazolam, 1'-hydroxymidazolam and digoxin by liquid chromatography/tandem mass spectrometry: application to an in vivo study to simultaneously measure P-glycoprotein and cytochrome P450 3A activity.
    Xue X; Huang M; Xiao H; Qin X; Huang L; Zhong G; Bi H
    J Pharm Biomed Anal; 2011 Apr; 55(1):187-93. PubMed ID: 21316177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS assay for quantitative determination of cardio glycoside in human blood samples.
    Frommherz L; Köhler H; Brinkmann B; Lehr M; Beike J
    Int J Legal Med; 2008 Mar; 122(2):109-14. PubMed ID: 17569072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of digoxin, digitoxin and their potential metabolites, impurities or degradation products by high-performance liquid chromatography.
    Desta B; Kwong E; McErlane KM
    J Chromatogr; 1982 May; 240(1):137-43. PubMed ID: 7096512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a new ultra-high-performance liquid chromatography-tandem mass spectrometry method for the determination of digoxin and digitoxin in plasma: Comparison with a clinical immunoassay.
    Ballotari M; Taus F; Tolle G; Danese E; Dorizzi RM; Tagliaro F; Gottardo R
    Electrophoresis; 2022 May; 43(9-10):1019-1026. PubMed ID: 35132652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No endogenous ouabain is detectable in human plasma by ultra-sensitive UPLC-MS/MS.
    Baecher S; Kroiss M; Fassnacht M; Vogeser M
    Clin Chim Acta; 2014 Apr; 431():87-92. PubMed ID: 24508998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatography-ionspray mass spectrometry for the specific determination of digoxin and some related cardiac glycosides in human plasma.
    Tracqui A; Kintz P; Ludes B; Mangin P
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):101-9. PubMed ID: 9187389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional (positive/negative) interference in a digoxin immunoassay: importance of antibody specificity.
    Datta P; Dasgupta A
    Ther Drug Monit; 1998 Jun; 20(3):352-7. PubMed ID: 9631936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a straightforward and rapid method for the therapeutic drug monitoring of digitoxin by LC-MS/MS.
    Bremer-Streck S; Kiehntopf M; Ihle S; Boeer K
    Clin Biochem; 2013 Nov; 46(16-17):1728-33. PubMed ID: 23954852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolonged half-life of digitoxin in the elderly].
    Bøhmer T; Røseth A
    Tidsskr Nor Laegeforen; 1999 Jan; 119(3):369-70. PubMed ID: 10074832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changed digitalis dosing].
    Reikvam A
    Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1324. PubMed ID: 20596094
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of cardiac glycoside drug interactions.
    Hooymans PM; Merkus FW
    Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific and sensitive determination of digoxin and metabolites in human serum by high performance liquid chromatography with cyclodextrin solid-phase extraction and precolumn fluorescence derivatization.
    Tzou MC; Sams RA; Reuning RH
    J Pharm Biomed Anal; 1995 Nov; 13(12):1531-40. PubMed ID: 8788139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a high performance liquid chromatography method and a liquid chromatography-tandem mass spectrometry method with pressurized liquid extraction for simultaneous quantification and confirmation of cyromazine, melamine and its metabolites in foods of animal origin.
    Yu H; Tao Y; Chen D; Wang Y; Liu Z; Pan Y; Huang L; Peng D; Dai M; Liu Z; Yuan Z
    Anal Chim Acta; 2010 Dec; 682(1-2):48-58. PubMed ID: 21056714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA-Based Assay for Digoxin Detection.
    Kjelstrup MV; Nielsen LDF; Hansen-Bruhn M; Gothelf KV
    Biosensors (Basel); 2018 Mar; 8(1):. PubMed ID: 29509662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a quantification method for digoxin, a typical P-glycoprotein probe in clinical and non-clinical studies, using high performance liquid chromatography-tandem mass spectrometry: the usefulness of negative ionization mode to avoid competitive adduct-ion formation.
    Hirabayashi H; Sugimoto H; Matsumoto S; Amano N; Moriwaki T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(32):3837-44. PubMed ID: 22098716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.